Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of Social Cognition via Hallucinogens and “Entactogens”
Katrin H. Preller, Franz X. Vollenweider
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 52

Showing 26-50 of 52 citing articles:

The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis
Carla Soares, Gerardo Gonzalo, João Castelhano, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105325-105325
Open Access | Times Cited: 8
The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies
João Castelhano, Gisela Lima, Marta Teixeira, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review
Ron Shore, K. Dobson, Nina Thomson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task
Amit Olami, Leehe Peled‐Avron
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Michael D. Wunderli, Matthias Vonmoos, Lorena Treichler, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 21, Iss. 4, pp. 333-344
Open Access | Times Cited: 20
Bedside to bench: the outlook for psychedelic research
Victor P. Acero, Emily S. Cribas, Kevin D. Browne, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
The behavioral and neurochemical characterization of a Drosophila dysbindin mutant supports the contribution of serotonin to schizophrenia negative symptoms
Sergio Hidalgo, Christian Castro, Rafaella V. Zárate, et al.
Neurochemistry International (2020) Vol. 138, pp. 104753-104753
Closed Access | Times Cited: 12
Hallucinations and Hallucinogens: Psychopathology or Wisdom?
José Carlos Bouso, Genı́s Ona, Maja Kohek, et al.
Culture Medicine and Psychiatry (2023) Vol. 47, Iss. 2, pp. 576-604
Open Access | Times Cited: 4
A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets
Judit Biosca-Brull, Genı́s Ona, Lineth Alarcón-Franco, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Richard J. Zeifman
(2024)
Open Access | Times Cited: 1
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects
Nathalie M. Rieser, Timo Torsten Schmidt, Katrin H. Preller
Current topics in behavioral neurosciences (2024)
Closed Access | Times Cited: 1
Psilocybin increases emotional empathy in patients with major depression
Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 1
Psychedelics and fNIRS neuroimaging: exploring new opportunities
Felix Scholkmann, Franz X. Vollenweider
Neurophotonics (2022) Vol. 10, Iss. 01
Open Access | Times Cited: 7
LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals
Isabel Wießner, Marcelo Falchi, Dimitri Daldegan‐Bueno, et al.
European Neuropsychopharmacology (2023) Vol. 68, pp. 89-104
Closed Access | Times Cited: 3
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns
Brian A. Baldo
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2409-2427
Closed Access
How Psychedelics Can Increase Moral Concern
Danica Dillion, Curtis Puryear, Kurt Gray
Oxford University Press eBooks (2024)
Closed Access
The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review
Laura Ramos, Selene Vicente
Journal of Clinical and Experimental Neuropsychology (2024) Vol. 46, Iss. 5, pp. 393-421
Closed Access
How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change
Richard J. Zeifman
(2024)
Open Access
Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories
C. J. Healy, Aaron Frazier, Stephen Kirsch, et al.
(2024)
Open Access
Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol
Sarah A. Smith, S. Smith, Liz Dennett, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307491-e0307491
Open Access
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders
Vivian Kim, Scott Wilson, Mary E. Woesner
Journal of Clinical Psychopharmacology (2024)
Closed Access
Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample
Grant Jones, Joshua Lipson, Erica Wang
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition
Pablo Mallaroni, Natasha L. Mason, Johannes T. Reckweg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Experiencias psicodélicas: fenomenología, potenciales terapéuticos y modelos explicativos
Tamara Chernoff, Bruno Kliger, Dante Hernán Venturini
Vertex Revista Argentina de Psiquiatría (2023) Vol. 34, Iss. 160, pp. 100-112
Open Access

Scroll to top